A Prospective, open-label Post-marketing clinical Follow-up study aims to assess the safety, performance, and user acceptance of the 72 Hours TraxIt® Cholesteric Liquid Crystal (CLC) Skin Patch Thermometer in a real-world clinical setting - NA

Medical Indicators Inc0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1. Subjects will be recruited from both in-patient and out-patient settings of mixed population, adults, pediatric and elderly individuals.
•i. Adults aged 18 to 65 years
•ii. Pediatric patients
•Infants – 6 month to 1 aged Toddlers- 1 to 3 years
•Children- 3 years to 12 years
•iii. Adolescents- 12 years to 18 years
•iv. Elderly individual aged 65 years and above
•2. Able to provide inform consent form and for pediatric patients from legal guardian.
•3. Inpatients admitted to the hospital for various medical conditions requiring continuous temperature monitoring.
•4. Outpatient with chronic conditions or specific health conditions that necessitate continuous temperature monitoring

•1. Children with skin condition or wounds in the patch application area.
•2. Children with cognitive impairments affecting their ability to wear patch or follow instruction.
•3. Individual with known allergies to adhesives or skin sensitivities in the patch application area.

发起方

Medical Indicators Inc